NEULASTA 6 MG/0.6 ML SYRINGE

pegfilgrastim
$10074.9000per ML

Strength

6 mg/.6mL

Manufacturer

Amgen Inc.

NDC

55513019001

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

10/24/2018

Active Ingredients

PEGFILGRASTIM

Approval Type

Biologic (BLA)

FDA Application

BLA125031

On Market Since

4/1/2002

Pharmacological Classes

Granulocyte Colony-Stimulating Factor
Increased Myeloid Cell Production
Leukocyte Growth Factor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+53.0%

Generic Alternatives

Save up to 68%

1 alternative • Same active ingredient